This paper is in the following e-collection/theme issue:

Authors' Responses to Peer-Reviews (92)

Published on in Vol 2, No 3 (2021): Jul-Sep

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/33496, first published .
Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study”

Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study”

Authors' Response to Peer Reviews of “Early Experience With Neutralizing Monoclonal Antibody Therapy for COVID-19: Retrospective Cohort Survival Analysis and Descriptive Study”

Authors of this article:

Mark Jarrett1 Author Orcid Image ;   Warren Licht1 Author Orcid Image ;   Kevin Bock1 Author Orcid Image ;   Zenobia Brown1 Author Orcid Image ;   Jamie Hirsch1 Author Orcid Image ;   Kevin Coppa2 Author Orcid Image ;   Rajdeep Brar1 Author Orcid Image ;   Stephen Bello2 Author Orcid Image ;   Ira Nash1 Author Orcid Image
Article Authors Cited by Tweetations (2) Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.